Skip to content
  • Facebook
  • X
  • Instagram
  • Email

MND Research Blog

Taking you behind the scenes of MND research

  • Home
  • About this blog
    • About us
    • How to use this blog
      • Comments policy
  • Blog Categories
    • Research we fund
    • Treatments
      • Clinical Trials
      • Unproven treatments
    • Causes and disease mechanisms
    • Markers of Disease Progression
    • Models of MND
    • Healthcare
    • Symposium
      • 35th Symposium: Montreal
      • 34th Symposium: Basel
      • 33rd Symposium: Virtual
      • 32nd Symposium: Virtual
  • Back to Basics
  • Glossary

Tag: Nuedexta

  • Home
  • Nuedexta
Treatments

Drug for uncontrollable laughing and crying is moving toward European licensing

6 October 2011

Reading Time: 2 minutesIn December last year, we told you about a new drug for uncontrollable laughter and crying (known as the pseudobulbar affect) called Nuedexta that had been approved for

Read More
21st Symposium: Orlando 2010 Clinical Trials Symposium Treatments

New drug for symptom control presented at symposium

11 December 2010

Reading Time: < 1 minuteSharing information at the symposium is what it’s all about. Today, Randall Kaye, chief medical officer from Avanir Pharmaceuticals, chose the symposium to give a presentation on

Read More

Follow us on Twitter/X

Follow @mndresearch

Useful Links

  • MND Association Website
  • International Symposium
  • MND Clinical Studies Group

The official blog of the

Copyright © 2025 MND Research Blog - MND Association. All rights reserved. Registered Charity no. 294354